Reflects CMS Open Payments as of 2026-07-26T04:22:22Z. CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
Covered recipient · General Payments record
JACOB SCHULTZ
A name match is not confirmation of identity. Check the NPI, specialty, and location before drawing any conclusion about a specific person.
This record has limited reported data for this program year and is not featured in search indexes. The records below are complete; see the methodology for how featured pages are determined.
This page merges CMS profile IDs 11302287, 11463041 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2021–2025
$1,760.88
- Reported across 84 records
- CMS publication 2026-06-30
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $692.53 | 34 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $77.07 | 3 |
| Acerta Pharma LLC | $59.42 | 3 |
| ABBVIE INC. | $58.88 | 3 |
| Corcept Therapeutics | $41.18 | 2 |
| Astellas Pharma US Inc | $38.71 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $38.34 | 2 |
| Phathom Pharmaceuticals, Inc. | $36.03 | 2 |
| PFIZER INC. | $35.11 | 2 |
| Corium, Inc. | $34.12 | 1 |
| Novo Nordisk AS | $33.75 | 2 |
| ITI, Inc. | $31.94 | 1 |
| Verona Pharma, Inc. | $24.23 | 1 |
| Neos Therapeutics, LP | $24.20 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.72 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.19 | 1 |
| Amgen Inc. | $18.69 | 1 |
| Lilly USA, LLC | $18.53 | 1 |
| Axsome Therapeutics, Inc. | $17.95 | 1 |
| Esperion Therapeutics, Inc. | $17.49 | 1 |
| Merck Sharp & Dohme Corporation | $16.44 | 1 |
| Amneal Pharmaceuticals LLC | $14.96 | 1 |
| Organon LLC | $13.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (34)
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
- Merged CMS profile IDs
- 11302287, 11463041
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.